Gilead Sets Price for Covid Treatment Remdesivir

Gilead Sets Price for Covid Treatment Remdesivir

Gilead Sciences, the biotech company based out of California that created one of the first original treatments for Covid, has set the price for remdesivir between $2,340 and $3,120 for a typical course treatment. While remdesivir has still yet to prove to reduce...
FDA Grants EUA for Covid Treatment Remdesivir from Gilead

FDA Grants EUA for Covid Treatment Remdesivir from Gilead

The FDA announced today (5/1) that it would grant EUA for Gilead for their antiviral drug remdesivir for treatment in early response to suspected or confirmed patients with Covid. This authorization will allow the distribution of the drug all over the US, as well as...